Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights

Go back to Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
(NYSE: MTNB) Delayed: 0.65 --0 (-0%)
Previous Close $0.65    52 Week High $2.01 
Open $0.64    52 Week Low $0.41 
Day High $0.66    P/E N/A 
Day Low $0.64    EPS $0.00 
Volume 49,626